Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K B Low

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1983
F sex factor of Escherichia coli K-12 codes for a single-stranded DNA binding proteinA L Kolodkin, M A Capage, E I Golub, et al.
Journal of Bacteriology|September 7, 2001
Extragenic suppressors of growth defects in msbB SalmonellaS R Murray, D Bermudes, K S de Felipe, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1981
Identification of a sex-factor-affinity site in E. coli as gamma deltaM S Guyer, R R Reed, J A Steitz, et al.
Radiation Research|August 1, 1978
Radiosensitization, mutagenicity, and toxicity of Escherichia coli by several nitrofurans and nitroimidazolesH Chessin, T McLaughlin, Z Mroczkowski, et al.
Cell|September 10, 1993
Folding in vivo of bacterial cytoplasmic proteins: role of GroELA L Horwich, K B Low, W A Fenton, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Antitumour effects of genetically engineered Salmonella in combination with radiationJ Platt, S Sodi, M Kelley, et al.
Journal of Bacteriology|October 1, 1974
Isolation and partial characterization of a temperature-sensitive Escherichia coli mutant with altered glutaminyl-transfer ribonucleic acid synthetaseA Körner, B B Magee, B Liska, et al.
Biotechnology & Genetic Engineering Reviews|September 4, 2001
Tumour-selective Salmonella-based cancer therapyD Bermudes, K B Low, J Pawelek, et al.
The Journal of Infectious Diseases|June 6, 2000
Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimuriumC Clairmont, K C Lee, J Pike, et al.
Nature Biotechnology|January 27, 1999
Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivoK B Low, M Ittensohn, T Le, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1983
F sex factor of Escherichia coli K-12 codes for a single-stranded DNA binding proteinA L Kolodkin, M A Capage, E I Golub, et al.
Journal of Bacteriology|September 7, 2001
Extragenic suppressors of growth defects in msbB SalmonellaS R Murray, D Bermudes, K S de Felipe, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1981
Identification of a sex-factor-affinity site in E. coli as gamma deltaM S Guyer, R R Reed, J A Steitz, et al.
Radiation Research|August 1, 1978
Radiosensitization, mutagenicity, and toxicity of Escherichia coli by several nitrofurans and nitroimidazolesH Chessin, T McLaughlin, Z Mroczkowski, et al.
Cell|September 10, 1993
Folding in vivo of bacterial cytoplasmic proteins: role of GroELA L Horwich, K B Low, W A Fenton, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Antitumour effects of genetically engineered Salmonella in combination with radiationJ Platt, S Sodi, M Kelley, et al.
Journal of Bacteriology|October 1, 1974
Isolation and partial characterization of a temperature-sensitive Escherichia coli mutant with altered glutaminyl-transfer ribonucleic acid synthetaseA Körner, B B Magee, B Liska, et al.
Biotechnology & Genetic Engineering Reviews|September 4, 2001
Tumour-selective Salmonella-based cancer therapyD Bermudes, K B Low, J Pawelek, et al.
The Journal of Infectious Diseases|June 6, 2000
Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimuriumC Clairmont, K C Lee, J Pike, et al.
Nature Biotechnology|January 27, 1999
Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivoK B Low, M Ittensohn, T Le, et al.
Pageof 4